Drug Trial Radar · NCT01268215
Pilot Study of Topical Steroid for Prevention of Chronic Lung Disease in Extremely Premature Infants.
Last checked: Nov 20, 2026Latest source record: Dec 29, 2010 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
45
Planned (sponsor's estimate)
Start
Jul 2010
Primary completion
Jun 2012
Study completion Dec 2013
Sponsor
- Lead sponsor
- East Carolina UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Dec 29, 2010
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- Who can join
- All sexes, from 24 weeks, up to 28 weeks
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Pilot study to evaluate the safety and the efficacy of endotracheal instillation of pulmonary surfactant, with or without topical steroid (Budesonide), as a prophylactic treatment for Bronchopulmonary Dysplasia (a form of chronic lung disease) in extremely low birth weight infants. Cytokines (a group of inflammatory mediators) are measured in the tracheal aspirate before and after instillation of the study drugs.
Conditions
- Bronchopulmonary Dysplasia
Interventions
InfasurfDrug
Endotracheal instillation of Infasurf once per week for three weeks
PulmicortDrug
Endotracheal instillation, once per week for three weeks
ShamOther
None instilled through the endotracheal tube
Primary outcomes
What the sponsor says the trial is designed to measure.
- To measure the effect of surfactant with and without Budesonide on the development of BPD in ELBW infants.Time frame: Supplemental oxygen requirement at 36 weeks' postmenstrual age (PMA)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
NICU-Pitt County Memorial Hospital
Greenville, North Carolina · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.